Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments – Forecast to 2028
Japan In Vitro Diagnostics (IVD) market is predicted to surpass US$ 5.5 Billion by 2028. Japan is one of the leading clinical laboratory markets in the Asia–Pacific region, and one of the largest markets for in vitro diagnostics (IVD) in the world. Japan is facing the challenges of fighting with infectious disease including HBV, TB, HCV, and HIV, as well as various chronic disease and cancer. The population of Japan is aging rapidly. For instance, as of November 2022, close to 36.5 million people in Japan were estimated to be within the age group 65 and over. Thus, Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.
Japan In Vitro Diagnostics (IVD) Market – Recent Developments
This 200 Page report with 42 Figures and 4 Tables has been analyzed from 8 View Points:
1) Japan In-Vitro Diagnostics (IVD) Market and Forecast (2008 – 2028)
2) Japan IVD Market Share and Forecast (2008 – 2028)
3) Japan IVD Market & Forecast – By Segment (2008 – 2028)
4) Japan IVD Market & Forecast – Company Sales Analysis (2014 – 2028)
5) Japan IVD Market – Major Deals
6) Japan IVD Market – Recent Developments
7) Registration for In Vitro Diagnostic Devices in Japan
8) Japan IVD Market - Drivers & Challenges
Japan IVD Market – By Segment
1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. SMBG
5. Tumor Marker
6. Immunoassay
7. Infectious Disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others
Japan IVD Sales & Forecast – By Company
1. Roche Diagnostics
2. Abbott Laboratories
3. Danaher Corporation
4. Biomerieux
5. Sysmex Corporation
6. Bio-Rad Laboratories, Inc
7. Becton Dickinson Company
8. Thermo Fisher Scientific Inc.
9. Others
Data Source
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Japan In Vitro Diagnostics (IVD) Market – Recent Developments
- In April 2023, Oxford Nanopore Technologies plc, and bioM?rieux SA teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
- In December 2022, bioM?rieux announced the CE-marking of VIDAS KUBE, the next generation automated immunoassay system for the VIDAS range.
- In July 2022, DiaCarta Inc., a molecular diagnostics company announced that the company has received CE-IVD Mark for its newly developed QuantiVirus SARS-CoV-2 & Flu A/B test.
- On segment basis, Genetic Testing and Clinical Chemistry are the leading segment of the Japan IVD market.
- Immunoassay stands at the 3rd leading spot in the Japan in vitro diagnostics market.
- Tumor Marker and Hematology segments are competing closely with each other to grab maximum share of the pie.
- Infectious disease segment contributed over 10 percent to the Japan IVD market in 2022.
- In the Japan IVD market, Roche Diagnostics is the leader, followed by Sysmex Corporation.
- Abbott Laboratories, Thermo Fisher Scientific Inc., and Danaher Corporation are the other top three players in the Japan IVD market.
- In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
- In April 2023, bioM?rieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System.
This 200 Page report with 42 Figures and 4 Tables has been analyzed from 8 View Points:
1) Japan In-Vitro Diagnostics (IVD) Market and Forecast (2008 – 2028)
2) Japan IVD Market Share and Forecast (2008 – 2028)
3) Japan IVD Market & Forecast – By Segment (2008 – 2028)
4) Japan IVD Market & Forecast – Company Sales Analysis (2014 – 2028)
5) Japan IVD Market – Major Deals
6) Japan IVD Market – Recent Developments
7) Registration for In Vitro Diagnostic Devices in Japan
8) Japan IVD Market - Drivers & Challenges
Japan IVD Market – By Segment
1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. SMBG
5. Tumor Marker
6. Immunoassay
7. Infectious Disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others
Japan IVD Sales & Forecast – By Company
1. Roche Diagnostics
2. Abbott Laboratories
3. Danaher Corporation
4. Biomerieux
5. Sysmex Corporation
6. Bio-Rad Laboratories, Inc
7. Becton Dickinson Company
8. Thermo Fisher Scientific Inc.
9. Others
Data Source
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
1. EXECUTIVE SUMMARY
2. JAPAN IN–VITRO DIAGNOSTICS (IVD) MARKET AND MARKET SHARE ANALYSIS – FORECAST TO 2028
2.1 Japan IVD Market and Forecast (2008 – 2028)
2.2 By Segment – Japan IVD Market Share and Forecast (2008 – 2028)
2.3 By Company – Japan IVD Share and Forecast (2015 – 2028)
3. JAPAN IVD – SEGMENTS WISE MARKET AND FORECAST (2008 – 2028)
3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious Disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast
4. JAPAN IVD MARKET – COMPANY WISE SALES ANALYSIS (2014 – 2028)
4.1 Roche Diagnostics
4.1.1 Business Overview
4.1.2 Roche Diagnostics – Japan IVD Sales and Forecast
4.1.3 Recent Developments
4.2 Abbott Laboratories
4.2.1 Business Overview
4.2.2 Abbott Laboratories – Japan IVD Sales and Forecast
4.2.3 Recent Developments
4.3 Danaher Corporation
4.3.1 Business Overview
4.3.2 Danaher Corporation – Japan IVD Sales and Forecast
4.3.3 Recent Initiatives/ Strategy/ Developments
4.4 Biomerieux
4.4.1 Business Overview
4.4.2 Biomerieux – Japan IVD Sales and Forecast
4.4.3 Recent Initiatives/ Strategy/ Developments
4.5 Sysmex Corporation
4.5.1 Business Overview
4.5.2 Sysmex Corporation – Japan IVD Sales and Forecast
4.5.3 Recent Initiatives/ Strategy/ Developments
4.6 Bio–Rad Laboratories, Inc
4.6.1 Business Overview
4.6.2 Bio–Rad Laboratories, Inc – Japan IVD Sales and Forecast
4.6.3 Recent Initiatives/ Strategy/ Developments
4.7 Becton Dickinson and Company
4.7.1 Business Overview
4.7.2 Becton Dickinson and Company – Japan IVD Sales and Forecast
4.7.3 Recent Initiatives/ Strategy/ Developments
4.8 Thermo Fisher Scientific Inc.
4.8.1 Business Overview
4.8.2 Thermo Fisher Scientific Inc. – Japan IVD Sales and Forecast
4.8.3 Recent Initiatives/ Strategy/ Developments
4.9 Others – Japan IVD Sales and Forecast
5. JAPAN IVD MARKET – MAJOR DEALS
5.1 2023
5.2 2022
5.3 2021
5.4 2020
5.5 2019
6. IN-VITRO DIAGNOSTICS (IVD) MARKET - RECENT DEVELOPMENTS
7. JAPAN IVD MARKET – DRIVING FACTORS
7.1 Technology Advancement Spurring the IVD Market
7.2 Increasing Geriatric Population
7.3 High Prevalence of Chronic and Infectious Diseases
8. JAPAN IVD MARKET – CHALLENGES
8.1 Cumbersome Reimbursement Procedure
8.2 Stringent Regulatory Framework
8.3 Operational Barriers Faced in Conducting Diagnostic Tests
2. JAPAN IN–VITRO DIAGNOSTICS (IVD) MARKET AND MARKET SHARE ANALYSIS – FORECAST TO 2028
2.1 Japan IVD Market and Forecast (2008 – 2028)
2.2 By Segment – Japan IVD Market Share and Forecast (2008 – 2028)
2.3 By Company – Japan IVD Share and Forecast (2015 – 2028)
3. JAPAN IVD – SEGMENTS WISE MARKET AND FORECAST (2008 – 2028)
3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious Disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast
4. JAPAN IVD MARKET – COMPANY WISE SALES ANALYSIS (2014 – 2028)
4.1 Roche Diagnostics
4.1.1 Business Overview
4.1.2 Roche Diagnostics – Japan IVD Sales and Forecast
4.1.3 Recent Developments
4.2 Abbott Laboratories
4.2.1 Business Overview
4.2.2 Abbott Laboratories – Japan IVD Sales and Forecast
4.2.3 Recent Developments
4.3 Danaher Corporation
4.3.1 Business Overview
4.3.2 Danaher Corporation – Japan IVD Sales and Forecast
4.3.3 Recent Initiatives/ Strategy/ Developments
4.4 Biomerieux
4.4.1 Business Overview
4.4.2 Biomerieux – Japan IVD Sales and Forecast
4.4.3 Recent Initiatives/ Strategy/ Developments
4.5 Sysmex Corporation
4.5.1 Business Overview
4.5.2 Sysmex Corporation – Japan IVD Sales and Forecast
4.5.3 Recent Initiatives/ Strategy/ Developments
4.6 Bio–Rad Laboratories, Inc
4.6.1 Business Overview
4.6.2 Bio–Rad Laboratories, Inc – Japan IVD Sales and Forecast
4.6.3 Recent Initiatives/ Strategy/ Developments
4.7 Becton Dickinson and Company
4.7.1 Business Overview
4.7.2 Becton Dickinson and Company – Japan IVD Sales and Forecast
4.7.3 Recent Initiatives/ Strategy/ Developments
4.8 Thermo Fisher Scientific Inc.
4.8.1 Business Overview
4.8.2 Thermo Fisher Scientific Inc. – Japan IVD Sales and Forecast
4.8.3 Recent Initiatives/ Strategy/ Developments
4.9 Others – Japan IVD Sales and Forecast
5. JAPAN IVD MARKET – MAJOR DEALS
5.1 2023
5.2 2022
5.3 2021
5.4 2020
5.5 2019
6. IN-VITRO DIAGNOSTICS (IVD) MARKET - RECENT DEVELOPMENTS
7. JAPAN IVD MARKET – DRIVING FACTORS
7.1 Technology Advancement Spurring the IVD Market
7.2 Increasing Geriatric Population
7.3 High Prevalence of Chronic and Infectious Diseases
8. JAPAN IVD MARKET – CHALLENGES
8.1 Cumbersome Reimbursement Procedure
8.2 Stringent Regulatory Framework
8.3 Operational Barriers Faced in Conducting Diagnostic Tests
LIST OF FIGURES:
Figure 2-1: Japan – IVD Market (Million US$), 2008 – 2022
Figure 2-2: Japan – Forecast for IVD Market (Million US$), 2023 – 2028
Figure 3-1: Japan – Urine & Feces Market (Million US$), 2008 – 2022
Figure 3-2: Japan – Forecast for Urine & Feces Market (Million US$), 2023 – 2028
Figure 3-3: Japan – Hematology Market (Million US$), 2008 – 2022
Figure 3-4: Japan – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure 3-5: Japan – Clinical Chemistry Market (Million US$), 2008 – 2022
Figure 3-6: Japan – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure 3-7: Japan – SMBG Market (Million US$), 2008 – 2022
Figure 3-8: Japan – Forecast for SMBG Market (Million US$), 2023 – 2028
Figure 3-9: Japan – Tumor Marker Market (Million US$), 2008 – 2022
Figure 3-10: Japan – Forecast for Tumor Marker Market (Million US$), 2023 – 2028
Figure 3-11: Japan – Immunoassay Market (Million US$), 2008 – 2022
Figure 3-12: Japan – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure 3-13: Japan – Infectious Disease Market (Million US$), 2008 – 2022
Figure 3-14: Japan – Forecast for Infectious disease Market (Million US$), 2023 – 2028
Figure 3-15: Japan – Microbiology Market (Million US$), 2008 – 2022
Figure 3-16: Japan – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure 3-17: Japan – Pathology Market (Million US$), 2008 – 2022
Figure 3-18: Japan – Forecast for Pathology Market (Million US$), 2023 – 2028
Figure 3-19: Japan – Genetic Testing Market (Million US$), 2008 – 2022
Figure 3-20: Japan – Forecast for Genetic Testing Market (Million US$), 2023 – 2028
Figure 3-21: Japan – Others Market (Million US$), 2008 – 2022
Figure 3-22: Japan – Forecast for Others Market (Million US$), 2023 – 2028
Figure 4-1: Roche Diagnostics – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-2: Roche Diagnostics – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-3: Abbott Laboratories – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-4: Abbott Laboratories – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-5: Danaher Corporation – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-6: Danaher Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-7: biomerieux – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-8: Biomerieux – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-9: Sysmex Corporation – Japan IVD Sales (Million US$), 2010 – 2022
Figure 410: Sysmex Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-11: Bio–Rad Laboratories, Inc – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-12: Bio–Rad Laboratories, Inc – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-13: Becton Dickinson and Company – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-14: Becton Dickinson and Company – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-15: Thermo Fisher Scientific Inc. – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-16: Thermo Fisher Scientific Inc. – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-17: Others – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-18: Others – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 2-1: Japan – IVD Market (Million US$), 2008 – 2022
Figure 2-2: Japan – Forecast for IVD Market (Million US$), 2023 – 2028
Figure 3-1: Japan – Urine & Feces Market (Million US$), 2008 – 2022
Figure 3-2: Japan – Forecast for Urine & Feces Market (Million US$), 2023 – 2028
Figure 3-3: Japan – Hematology Market (Million US$), 2008 – 2022
Figure 3-4: Japan – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure 3-5: Japan – Clinical Chemistry Market (Million US$), 2008 – 2022
Figure 3-6: Japan – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure 3-7: Japan – SMBG Market (Million US$), 2008 – 2022
Figure 3-8: Japan – Forecast for SMBG Market (Million US$), 2023 – 2028
Figure 3-9: Japan – Tumor Marker Market (Million US$), 2008 – 2022
Figure 3-10: Japan – Forecast for Tumor Marker Market (Million US$), 2023 – 2028
Figure 3-11: Japan – Immunoassay Market (Million US$), 2008 – 2022
Figure 3-12: Japan – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure 3-13: Japan – Infectious Disease Market (Million US$), 2008 – 2022
Figure 3-14: Japan – Forecast for Infectious disease Market (Million US$), 2023 – 2028
Figure 3-15: Japan – Microbiology Market (Million US$), 2008 – 2022
Figure 3-16: Japan – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure 3-17: Japan – Pathology Market (Million US$), 2008 – 2022
Figure 3-18: Japan – Forecast for Pathology Market (Million US$), 2023 – 2028
Figure 3-19: Japan – Genetic Testing Market (Million US$), 2008 – 2022
Figure 3-20: Japan – Forecast for Genetic Testing Market (Million US$), 2023 – 2028
Figure 3-21: Japan – Others Market (Million US$), 2008 – 2022
Figure 3-22: Japan – Forecast for Others Market (Million US$), 2023 – 2028
Figure 4-1: Roche Diagnostics – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-2: Roche Diagnostics – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-3: Abbott Laboratories – Japan IVD Sales (Million US$), 2012 – 2022
Figure 4-4: Abbott Laboratories – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-5: Danaher Corporation – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-6: Danaher Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-7: biomerieux – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-8: Biomerieux – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-9: Sysmex Corporation – Japan IVD Sales (Million US$), 2010 – 2022
Figure 410: Sysmex Corporation – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-11: Bio–Rad Laboratories, Inc – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-12: Bio–Rad Laboratories, Inc – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-13: Becton Dickinson and Company – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-14: Becton Dickinson and Company – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-15: Thermo Fisher Scientific Inc. – Japan IVD Sales (Million US$), 2014 – 2022
Figure 4-16: Thermo Fisher Scientific Inc. – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
Figure 4-17: Others – Japan IVD Sales (Million US$), 2015 – 2022
Figure 4-18: Others – Forecast for Japan IVD Sales (Million US$), 2023 – 2028
LIST OF TABLES:
Table 2-1: By Segment – Japan IVD Market Share (Percent), 2008 – 2022
Table 2-2: By Segment – Forecast for Japan IVD Market Share (Percent), 2023 – 2028
Table 2-3: By Company – Japan IVD Market Share (Percent), 2015 – 2022
Table 2-4: By Company – Forecast for Japan IVD Market Share (Percent), 2023 – 2028
Table 2-1: By Segment – Japan IVD Market Share (Percent), 2008 – 2022
Table 2-2: By Segment – Forecast for Japan IVD Market Share (Percent), 2023 – 2028
Table 2-3: By Company – Japan IVD Market Share (Percent), 2015 – 2022
Table 2-4: By Company – Forecast for Japan IVD Market Share (Percent), 2023 – 2028
